Clinical Trial Update: Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating phosphate binding with Sevelamer in stage 3 chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Chronic Kidney Disease

Drugs mentioned

• Sevelamer (sevelamer hydrochloride)

Snippet

Sponsor: University Hospital Birmingham NHS Foundation Trust | Conditions: Kidney Failure, Chronic, Cardiovascular Diseases | Phase 2 | Status: COMPLETED